DE69028712D1 - Zusammensetzung zur behandlung entzündlicher darmerkrankungen - Google Patents

Zusammensetzung zur behandlung entzündlicher darmerkrankungen

Info

Publication number
DE69028712D1
DE69028712D1 DE69028712T DE69028712T DE69028712D1 DE 69028712 D1 DE69028712 D1 DE 69028712D1 DE 69028712 T DE69028712 T DE 69028712T DE 69028712 T DE69028712 T DE 69028712T DE 69028712 D1 DE69028712 D1 DE 69028712D1
Authority
DE
Germany
Prior art keywords
treatment
inflammable
composition
intestinal diseases
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69028712T
Other languages
English (en)
Other versions
DE69028712T2 (de
Inventor
Richard I Breuer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69028712D1 publication Critical patent/DE69028712D1/de
Publication of DE69028712T2 publication Critical patent/DE69028712T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69028712T 1989-11-16 1990-11-15 Zusammensetzung zur behandlung entzündlicher darmerkrankungen Expired - Fee Related DE69028712T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/438,297 US5039703A (en) 1989-11-16 1989-11-16 Method for treating inflammatory bowel disorders
PCT/US1990/006697 WO1991007176A1 (en) 1989-11-16 1990-11-15 Method and composition for treating inflammatory bowel disorders

Publications (2)

Publication Number Publication Date
DE69028712D1 true DE69028712D1 (de) 1996-10-31
DE69028712T2 DE69028712T2 (de) 1997-03-20

Family

ID=23740078

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69028712T Expired - Fee Related DE69028712T2 (de) 1989-11-16 1990-11-15 Zusammensetzung zur behandlung entzündlicher darmerkrankungen

Country Status (11)

Country Link
US (1) US5039703A (de)
EP (1) EP0502925B1 (de)
AT (1) ATE143261T1 (de)
AU (2) AU6681790A (de)
CA (1) CA2071215C (de)
DE (1) DE69028712T2 (de)
DK (1) DK0502925T3 (de)
ES (1) ES2093695T3 (de)
GR (1) GR3021760T3 (de)
IL (1) IL96365A (de)
WO (1) WO1991007176A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
IT1273628B (it) * 1993-06-04 1997-07-08 Emerging Pharmaceutical Techno Composizioni farmaceutiche per la cura della talassemia contenenti derivati dell'acido butirrico e in particolare isobutirramide
WO1995011699A1 (en) * 1993-10-29 1995-05-04 The Trustees Of Boston University Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
CA2176719C (en) * 1993-11-17 2007-09-18 Geoffrey Anisson Fatty acid delivery system
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
AUPO763197A0 (en) 1997-06-30 1997-07-24 Sigma Pharmaceuticals Pty Ltd Health supplement
AU774861B2 (en) * 1998-02-11 2004-07-08 Douglas V Faller Compositions and methods for the treatment of cystic fibrosis
US6114382A (en) * 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
GB0127916D0 (en) * 2001-11-21 2002-01-16 Rowett Res Inst Method
ITMI20040187A1 (it) * 2004-02-06 2004-05-06 Cosmo Spa Composizioni farmaceutiche o dietetiche a base di acidi grassi a catena corta e zuccheri complessi per le disfunzioni intestinali
US20070071779A1 (en) * 2005-09-26 2007-03-29 Leggit Ingenuity, Llc Compositions for delivering lipophilic agents to the intestinal mucosa and method of making thereof
CN102245176B (zh) 2008-10-31 2015-05-27 脂质医药有限公司 用作药物的脂肪酸
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
EP2509418A4 (de) 2009-12-08 2013-03-20 Hemaquest Pharmaceuticals Inc Verfahren und niedrigdosierungspläne zur behandlung von erythrozytendysfunktion
JP4620169B1 (ja) * 2010-01-28 2011-01-26 株式会社三和化学研究所 有機酸重合体を有効成分とするクローン病の予防又は治療剤
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
ES2673276T3 (es) 2013-03-14 2018-06-21 University Of Ottawa Métodos para el diagnóstico y el tratamiento de la enfermedad inflamatoria intestinal
CA2962802A1 (en) * 2014-10-03 2016-04-07 University Of Ottawa Markers for inflammatory bowel disease
US11291693B2 (en) 2015-06-25 2022-04-05 Synlogic Operating Company, Inc. Bacteria engineered to treat metabolic diseases
US20190167615A1 (en) * 2016-08-10 2019-06-06 Monash University Metabolites for treatment and prevention of autoimmune disease
KR102665545B1 (ko) 2017-04-17 2024-05-13 더 유니버서티 오브 시카고 인간 건강에의 적용 및 질환의 치료를 위한 장으로의 단쇄 지방산의 전달을 위한 중합체 재료
KR20220034736A (ko) 2019-05-31 2022-03-18 비락타 서브시디어리 인크. 히스톤 데아세틸라제 억제제를 사용하여 바이러스 관련 암을 치료하는 방법

Also Published As

Publication number Publication date
ATE143261T1 (de) 1996-10-15
IL96365A (en) 1995-06-29
EP0502925A1 (de) 1992-09-16
DK0502925T3 (da) 1996-12-23
DE69028712T2 (de) 1997-03-20
EP0502925B1 (de) 1996-09-25
CA2071215C (en) 1997-02-04
GR3021760T3 (en) 1997-02-28
ES2093695T3 (es) 1997-01-01
AU664492B2 (en) 1995-11-16
EP0502925A4 (en) 1992-12-16
US5039703A (en) 1991-08-13
AU5051693A (en) 1994-01-13
AU6681790A (en) 1991-05-23
IL96365A0 (en) 1991-08-16
WO1991007176A1 (en) 1991-05-30
CA2071215A1 (en) 1991-05-17

Similar Documents

Publication Publication Date Title
DE69028712T2 (de) Zusammensetzung zur behandlung entzündlicher darmerkrankungen
ATE258065T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen
ATE17079T1 (de) Praeparat zur behandlung von wunden der hautoberflaeche und verfahren zur herstellung des praeparats.
DE69132688T2 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATA242288A (de) Dosierungsform für die behandlung kardiovaskulärer erkrankungen
ATE156704T1 (de) Neurologische wirkstoffe zur nasalen verabreichung an das gehirn
DE69327582T2 (de) Methoden zur Behandlung von Interleukin- 1 und - Tumor - Nekrose - Faktor - verursachten Krankheiten
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69426471D1 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
LV10689A (lv) Dimetilpolisiloksana pielietojums kunga un zarnu trakta slimibu arstesanai
DE3684904D1 (de) Pharmazeutisches praeparat zur behandlung von stoerungen des fettstoffwechsels (hyperlipoproteinaemien).
ATE40793T1 (de) Pharmazeutisches praeparat zur therapeutischen behandlung von rheumatischen erkrankungen.
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
FR2614203B1 (fr) Composition pharmaceutique pour le traitement des maladies de la peau et son procede de preparation.
FR2600256B1 (fr) Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
DE3784738D1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
MX9203208A (es) Composicion farmaceutica y metodo para el tratamiento de trastornos digestivos.
UA19794A (uk) Спосіб моделюваhhя виразки шлуhку
GR880100839A (el) Αλας τρομε?αμίνης του 1-με?ύλ-Β-ΟΞΟ-Α-(φαινυλοκαρβομουλό)-2-πυρρολοπροπιονιτριλίου.
ATE211914T1 (de) Wismuth enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden
DE68905479T2 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
GEP19981197B (en) Emulsion for Treatment of Ulcer Diseases

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee